Description
In 2017, the North American Menopause Society (NAMS) issued an updated statement related to the current recommendations for best practices in using HT (hormone therapy) for the treatment of menopause-related symptoms such as vasomotor symptoms (VMS). The 2017 Hormone Therapy Position Statement of the North American Menopause Society (NAMS) is an update to the previous statement issued in 2012.